LC
AEHR icon

Luminist Capital’s Aehr Test Systems AEHR Stock Holding History

Luminist Capital’s Portfolio AEHR Stock Details AEHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$288 Buy
+3
New +$274 ﹤0.01% 385

Other funds holding AEHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Luminist Capital's AEHR Position: Q2 2026 in Review

Luminist Capital opened a new position in Aehr Test Systems (AEHR) in Q2 2026: 3 shares worth $288. The stake represents ﹤0.01% of the portfolio and ranks #385 among its holdings.

262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

  • Luminist Capital held 3 shares of Aehr Test Systems worth $288 as of Q2 2026.
  • Aehr Test Systems was a new Luminist Capital position in Q2 2026.
  • Aehr Test Systems made up ﹤0.01% of Luminist Capital's portfolio in Q2 2026, its #385 holding.
  • 262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Luminist Capital's 13F filing for Q2 2026, filed 7 Aug 2026.